Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.

Similar presentations


Presentation on theme: "Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical."— Presentation transcript:

1 Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical and humanistic outcomes - Diabetes, hypertension, gout, mental health, HIV/AIDS, gout… - Novel pharmacy practice models Health Related Quality of Life (HRQOL) - Develop and assess instruments for clinical trials and practice - Gout Impact Scale (GIS) in multinational clinical trials for new therapies - Student Quality of Life, Stress, & Coping Skills

2 Core Expertise Assessing Patient Reported Outcomes (PROs) - Patient/subject perceptions, attitudes, knowledge, intentions, symptoms - Health Related Quality of Life (HRQOL) Instrument development and validation Assessment across patient groups, countries, cultures Assessing outcomes (ECHO) in patient populations - identify patients likely to benefit most from new intervention (best value) - change in outcomes due to new vs. usual care interventions Pre-market “value” of new pharmaceuticals - Economic, clinical and humanistic value propositions - Given current and likely future market conditions - Evidence required for reimbursement by payers all countries - Pharmacoeconomic research strategy and plan to collect and disseminate needed data

3 Proposed Collaborations with SSPPS Faculty Assessing Patient Reported Outcomes (PROs) - Patient/subject perceptions, attitudes, knowledge, intentions, symptoms - Health Related Quality of Life (HRQOL) Instrument development and validation Assessment across patient groups, countries, cultures Assessing outcomes (ECHO) in patient populations - identify patients likely to benefit most from new intervention (best value) - change in outcomes due to new vs. usual care interventions Pre-market “value” of new pharmaceuticals - Economic, clinical and humanistic value propositions - Given current and likely future market conditions - Evidence required for reimbursement by payers all countries - Pharmacoeconomic research strategy and plan to collect and disseminate needed data Clinical Faculty Pharm Sciences


Download ppt "Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical."

Similar presentations


Ads by Google